Literature DB >> 20182248

Extracorporeal shock wave therapy for nonunion of the tibia.

Eric A Elster1, Alexander Stojadinovic, Jonathan Forsberg, Scott Shawen, Romney C Andersen, Wolfgang Schaden.   

Abstract

OBJECTIVES: Delayed and nonunion of the tibia are not uncommon in orthopaedic practice. Multiple methods of treatment have been developed with variable results. The objective of this study was to define disease-specific and treatment-related factors of prognostic significance in patients undergoing shock wave therapy for tibia nonunion.
DESIGN: Retrospective analysis. PATIENTS: One hundred ninety-two patients treated with extracorporeal shock wave therapy (ESWT) at a single referral trauma center, AUVA-Trauma Center Meidling, a large single-referral trauma center located in Vienna, Austria, in an attempt to determine the feasibility and factors associated with the use of ESWT in the treatment for tibia nonunion. INTERVENTION: ESWT coupled with posttreatment immobilization, external fixation, or ESWT alone. MAIN OUTCOME MEASURES: Fracture healing, overall healing percent, and factors associated with ESWT success or failure.
RESULTS: At the time of last follow up, 138 of 172 (80.2%) patients have demonstrated complete fracture healing. Mean time from first shock wave therapy to complete healing of the tibia nonunion was 4.8+/-4.0 months. Number of orthopaedic operations (P=0.003), shock wave treatments (P=0.002), and pulses delivered (P=0.04) were significantly associated with complete bone healing. Patients requiring multiple (more than one) shock wave treatments versus a single treatment had a significantly lower likelihood of fracture healing (P=0.003). This may be attributable to the finding that a significantly greater proportion of patients with multiple rather than single ESWT treatments had three or more prior orthopaedic procedures (more than one ESWT, 63.9% versus one ESWT, 23.5%; P<0.001).
CONCLUSIONS: ESWT is a feasible treatment modality for tibia nonunion.

Entities:  

Mesh:

Year:  2010        PMID: 20182248     DOI: 10.1097/BOT.0b013e3181b26470

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  22 in total

1.  Pulsed focused ultrasound treatment of muscle mitigates paralysis-induced bone loss in the adjacent bone: a study in a mouse model.

Authors:  Sandra L Poliachik; Tatiana D Khokhlova; Yak-Nam Wang; Julianna C Simon; Michael R Bailey
Journal:  Ultrasound Med Biol       Date:  2014-05-21       Impact factor: 2.998

2.  [Extracorporal shock wave therapy for the treatment of pseudarthrosis : New experiences with an old technology].

Authors:  J Everding; M Freistühler; J Stolberg-Stolberg; M J Raschke; P Garcia
Journal:  Unfallchirurg       Date:  2017-11       Impact factor: 1.000

Review 3.  Extracorporeal shockwave therapy in musculoskeletal disorders.

Authors:  Ching-Jen Wang
Journal:  J Orthop Surg Res       Date:  2012-03-20       Impact factor: 2.359

4.  Human autologous mesenchymal stem cells with extracorporeal shock wave therapy for nonunion of long bones.

Authors:  Lei Zhai; Xin-Long Ma; Chuan Jiang; Bo Zhang; Shui-Tao Liu; Geng-Yan Xing
Journal:  Indian J Orthop       Date:  2016-09       Impact factor: 1.251

5.  Influence of extracorporeal shock wave therapy (ESWT) on bone turnover markers in organisms with normal and low bone mineral density during fracture healing: a randomized clinical trial.

Authors:  Christoph Wölfl; Laura Schuster; Bernd Höner; Sarah Englert; Roman Klein; Christoph Hirche; Matthias Münzberg; Paul Alfred Grützner; Ulrich Kneser; Leila Harhaus
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2017-12-18

6.  Tissue engineered strategies for pseudoarthrosis.

Authors:  Umile Giuseppe Longo; Ugo Trovato; Mattia Loppini; Giacomo Rizzello; Wasim Sardar Khan; Nicola Maffulli; Vincenzo Denaro
Journal:  Open Orthop J       Date:  2012-11-30

7.  Shockwave treatment for musculoskeletal diseases and bone consolidation: qualitative analysis of the literature.

Authors:  Paulo Kertzman; Mario Lenza; André Pedrinelli; Benno Ejnisman
Journal:  Rev Bras Ortop       Date:  2015-01-22

8.  Low energy shock wave therapy induces angiogenesis in acute hind-limb ischemia via VEGF receptor 2 phosphorylation.

Authors:  Johannes Holfeld; Can Tepeköylü; Stefan Blunder; Daniela Lobenwein; Elke Kirchmair; Marion Dietl; Radoslaw Kozaryn; Daniela Lener; Markus Theurl; Patrick Paulus; Rudolf Kirchmair; Michael Grimm
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

9.  Shock Wave Treatment Protects From Neuronal Degeneration via a Toll-Like Receptor 3 Dependent Mechanism: Implications of a First-Ever Causal Treatment for Ischemic Spinal Cord Injury.

Authors:  Daniela Lobenwein; Can Tepeköylü; Radoslaw Kozaryn; Elisabeth J Pechriggl; Mario Bitsche; Michael Graber; Helga Fritsch; Severin Semsroth; Nadia Stefanova; Patrick Paulus; Martin Czerny; Michael Grimm; Johannes Holfeld
Journal:  J Am Heart Assoc       Date:  2015-10-27       Impact factor: 5.501

Review 10.  Extracorporeal shock wave therapy in musculoskeletal disorders: a review.

Authors:  Pietro Romeo; Vito Lavanga; Davide Pagani; Valerio Sansone
Journal:  Med Princ Pract       Date:  2013-11-05       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.